The Landscape of Persister Cells in High-Risk Neuroblastoma
Liron Grossmann | Pediatric Hemato-Oncology Division, Sheba Medical Center, Ramat Gan, Israel
Keynote Lecture | New Therapeutic Approaches for Neuroblastoma
14:31
סגור לתגובות על Keynote Lecture | New Therapeutic Approaches for Neuroblastoma
Daniel Morgenstern | Solid Tumor Section, Hematology Oncology, Hospital for Sick Children, Toronto, Canada
Session IV – Neuroblastoma
14:28
סגור לתגובות על Session IV – Neuroblastoma
Sponsored by Takeda Chairs: Shifra Ash, Israel Dalia Waldman, Israel
Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I
14:17
סגור לתגובות על Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I
Mahdi Asleh | Pediatric Hematology Oncology, Soroka University Medical Center, Beer Sheva| Faculty of Medicine, Ben-Gurion University of the Negev,
RAS Pathway Mutations are the Driver of MDS in a Subset of Pediatric Patients
13:55
סגור לתגובות על RAS Pathway Mutations are the Driver of MDS in a Subset of Pediatric Patients
Asaf Yanir | BMT, Cell Processing Facility, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Long-Term Hematopoietic Dysfunction in Patients with Large-Scale Mitochondrial DNA Deletion Syndromes
13:12
סגור לתגובות על Long-Term Hematopoietic Dysfunction in Patients with Large-Scale Mitochondrial DNA Deletion Syndromes
Noa Greenberg-Kushnir | Pediatric Hemato-Oncology Division, Sheba Medical Center, Ramat Gan, Israel
Genetic Background and Clinical Characteristics of Congenital Neutropenias in Israel
12:43
סגור לתגובות על Genetic Background and Clinical Characteristics of Congenital Neutropenias in Israel
Orna Steinberg Shemer | Rina Zaizov Division of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Keynote Lecture | Germline Ribosomopathy-From Molecular Mechanisms to Targeted Therapy
12:41
סגור לתגובות על Keynote Lecture | Germline Ribosomopathy-From Molecular Mechanisms to Targeted Therapy
Alan J. Warren | Hematology Dept., School of Clinical Medicine, University of Cambridge, UK
Session III – Hematology
12:36
סגור לתגובות על Session III – Hematology
Chairs: Hagit Miskin, Israel Joanne Yacobovich, Israel
Keynote Lecture | Update on the Results of the RMS 2005 and the Aims of the FAR RMS
12:34
סגור לתגובות על Keynote Lecture | Update on the Results of the RMS 2005 and the Aims of the FAR RMS
Hans Merks | Pediatric Oncology, Princess Maxima Center, Utrecht, Netherlands
